How Do You Get Rid of Hot Flashes: Treatments That Work

Hormone therapy remains the most effective treatment for hot flashes, cutting their frequency by roughly three-quarters compared to placebo, but it is far from the only option that works. Several non-hormonal prescription medications, a newer class of drugs targeting the brain’s thermostat directly, behavioral strategies, and even some low-tech cooling approaches have evidence behind them. The right choice depends on how severe your hot flashes are, your medical history, and how comfortable you are with the trade-offs of each approach.

Why Hot Flashes Happen in the First Place

Hot flashes are triggered when small rises in your core body temperature set off a sweating response that would not have been triggered before menopause. Estrogen loss narrows what researchers call the thermoneutral zone, the temperature range your body tolerates before it decides it needs to cool down or warm up. When that zone shrinks, even a minor bump in temperature, like walking into a warm room or drinking something hot, can push you past the sweating threshold and launch a full-blown flush.¹ Estrogen plays a central role but is not the whole story, which is why treatments targeting other parts of the pathway can also help.

Hormone Therapy Is Still the Gold Standard

Estrogen-based hormone therapy (HT) consistently outperforms every other treatment. A Cochrane review found it reduces hot flash frequency by about 77% compared to placebo, with a significant reduction in severity as well.² Whether you take conjugated estrogen pills, oral estradiol, or a transdermal estradiol patch, the effect on hot flashes is roughly the same; head-to-head comparisons have not found meaningful differences among estrogen types.³

The lingering concern about hormone therapy traces back to early results from the Women’s Health Initiative, which linked HT to increased cardiovascular and breast cancer risks. But those headlines came mostly from women who started hormones well past menopause. Subanalyses of the same data, along with more recent trials, show that starting HT before age 60 or within ten years of menopause carries a low risk of adverse cardiovascular events.⁴ Animal studies showed the same pattern: estrogen slowed plaque buildup in arteries only when given soon after surgical menopause, and the benefit vanished when treatment was delayed until plaques had already become complex.⁵ This “timing hypothesis” has reshaped clinical guidelines. For women in early menopause with bothersome hot flashes and no history of hormone-sensitive cancer or blood clots, HT at the lowest effective dose for the shortest necessary duration is generally considered a reasonable first-line treatment.

Prescription Alternatives When Hormones Are Off the Table

Many women cannot or prefer not to take estrogen, especially those with a history of breast cancer. That is where non-hormonal prescription medications come in. None match estrogen’s potency, but several have solid evidence of benefit.

SSRIs and SNRIs

Certain antidepressants work on hot flashes even in women who are not depressed. A systematic review of clinical trials found that among the SSRIs, escitalopram, paroxetine, and fluoxetine showed the highest efficacy and safety, while venlafaxine and desvenlafaxine were the standout SNRIs.⁶ Another review reached a similar conclusion, identifying paroxetine, citalopram, and escitalopram as the most effective SSRIs and venlafaxine as the top first-line SNRI.⁷ In fact, low-dose paroxetine (sold as Brisdelle) is the only non-hormonal medication specifically FDA-approved for hot flashes.

A meta-analysis comparing various non-hormonal treatments with placebo found that SSRIs and SNRIs reduced daily hot flashes by about one episode per day more than placebo. That is a real but modest effect compared to estrogen, and the authors noted that most trials had methodological limitations.⁸ Side effects like nausea, dry mouth, and decreased libido can also limit their usefulness for some women.

Gabapentin

Gabapentin, a drug developed for seizures and nerve pain, has gained a following for hot flash management. A meta-analysis of seven trials found women on gabapentin reported roughly a 24% greater reduction in hot flash frequency and a 27% greater reduction in a composite score (combining frequency and severity) compared to placebo.⁹ One trial directly compared gabapentin at 300 mg per day with standard estrogen and found no significant difference in effectiveness between the two, suggesting gabapentin at an adequate dose can come close to estrogen for some women.¹⁰ Drowsiness is the main downside, which is why some clinicians prescribe it at bedtime, effectively doubling as a sleep aid for women whose nights are disrupted by sweats.

Fezolinetant and the Neurokinin Pathway

The most significant recent advance is fezolinetant (brand name Veozah), approved by the FDA in 2023. Instead of replacing estrogen or borrowing a drug from another condition, fezolinetant was designed from the ground up to target the neurokinin 3 (NK3) receptor in the hypothalamus, which is part of the brain circuitry that controls body temperature. Preclinical work showed that blocking this receptor in ovariectomized rats reduced hot-flash-like symptoms and calmed neuronal activity in the brain region responsible for thermoregulation, without affecting estrogen levels.¹¹ Phase 3 trials in humans confirmed meaningful reductions in both frequency and severity of moderate-to-severe hot flashes. Because it does not involve hormones, fezolinetant is an option for women who cannot take estrogen, including some breast cancer survivors, though long-term safety data are still accumulating. Liver enzyme monitoring is recommended during treatment.

Behavioral and Lifestyle Approaches

Not everything that helps comes from a pharmacy. Behavioral strategies can meaningfully reduce how often and how intensely hot flashes disrupt your day, and they carry essentially no risk.

Clinical hypnosis stands out among mind-body therapies. A scoping review comparing cognitive behavioral therapy (CBT) and clinical hypnosis found that while CBT helped women feel less bothered by hot flashes and cope better with the disruption, only clinical hypnosis significantly reduced the actual frequency and severity of episodes.¹² That is a meaningful distinction: CBT changes how you experience hot flashes, while hypnosis appears to change whether they happen. CBT remains worth considering if your main complaint is that hot flashes wreck your concentration or sleep, since reducing the bother can improve quality of life even if the flush count stays the same.

Weight loss also shows promise. A pilot study randomized women to either a behavioral weight loss program or a control group. Women in the weight loss arm lost an average of about 9 kg and reported significantly greater reductions in hot flashes. The correlation between pounds lost and flashes reduced was moderate and statistically significant.¹³ This is a pilot study, so the findings need confirmation in larger trials, but the direction makes physiological sense: excess body fat acts as insulation, trapping heat and making it harder to regulate core temperature.

Keeping Cool Actually Works

The recommendation to dress in layers, keep a fan nearby, and sip cold drinks sounds like something your grandmother might suggest, but it is backed by professional guidance from the North American Menopause Society for mild hot flashes.¹⁴ And emerging evidence suggests that targeted cooling can go beyond mild relief. A study testing a novel wrist-cooling device found that it reduced severe hot flash episodes by about 46% and total daily hot flashes by roughly 18% compared to baseline. The effect was consistent across different groups, including breast cancer patients, postmenopausal women, and prostate cancer patients receiving androgen deprivation therapy.¹⁵ The wrist is a good cooling target because blood vessels run close to the surface there, so cooling the skin can quickly lower the temperature of blood flowing back to the core.

Trigger avoidance is another simple strategy that costs nothing. Spicy food consumption has been significantly associated with increased odds of hot flashes.¹⁶ Alcohol, caffeine, and hot beverages are commonly cited triggers as well.¹⁷ Not every woman has the same triggers, so it can help to keep a simple diary for a week or two, noting what you ate, drank, or did in the hour before a flash. Patterns often emerge quickly.

Supplements and Herbal Remedies Have Mixed Evidence

Soy isoflavones are probably the most widely used supplement for hot flashes, but whether they help depends on your gut bacteria. Certain intestinal bacteria convert soy isoflavones into a compound called equol, and only about a third of Western women produce equol. A meta-analysis found that supplementing equol to women who do not naturally produce it significantly lowered hot flash scores.¹⁸ A separate trial found isoflavone supplementation improved hot flash and sweating scores only in equol producers.¹⁹ If you have tried soy supplements and found them useless, your equol-producer status is a plausible explanation. Testing for equol production is available, though not yet routine.

Black cohosh has a long traditional reputation, and some narrative reviews describe potential benefits for hot flashes and night sweats, with added vasorelaxation properties.²⁰ But a well-designed randomized controlled trial found that neither black cohosh nor red clover reduced vasomotor symptoms more than placebo over 12 months, though both were safe.²¹ An earlier review noted that most trials showing benefit had poor methodology, and that rare cases of liver toxicity had been reported, though a direct causal link was not established.²² The honest read on black cohosh is that it might help some women mildly, but the best-designed studies do not support it, and it is not something to rely on for moderate or severe symptoms.

Why Acupuncture Studies Are Misleading

Acupuncture is one of the most commonly sought complementary therapies for hot flashes, and at first glance the literature looks encouraging. An evidence update confirmed that acupuncture reduced hot flashes compared to no treatment.²³ The catch is that when acupuncture is compared to sham acupuncture, where needles are placed at non-traditional points or do not actually penetrate the skin, the difference disappears. A randomized trial comparing real Chinese-medicine acupuncture with non-insertive sham acupuncture found virtually identical hot flash scores in both groups.²⁴ This strongly suggests that the benefit women experience from acupuncture is a placebo or expectation effect, not a specific physiological one. If you enjoy acupuncture and find it relaxing, there is no harm, but the evidence does not support it as a standalone treatment for hot flashes.

The Placebo Effect Is Enormous in Hot Flash Trials

One of the quirkiest features of hot flash research is the size of the placebo response. A meta-analysis of paroxetine trials found that about 79% of the mean treatment response for hot flash frequency was accounted for by placebo, leaving a true drug effect of only about 21%. For severity, placebo accounted for roughly 68% of the response.²⁵ This does not mean paroxetine is ineffective, since the drug-minus-placebo difference is still statistically and clinically real. But it does mean that simply being in a study, getting attention from a provider, and expecting improvement can substantially reduce hot flashes. That is useful information: it suggests that feeling in control of your symptoms, paying attention to patterns, and having a management plan may produce real improvements independent of which specific treatment you choose.

Researchers investigating what drives these large placebo responses identified treatment period duration, number of treatment arms in a trial, and baseline BMI as factors.²⁶ For you as a patient, the practical takeaway is that expectations matter. If you start a new treatment feeling hopeful and engaged, you are more likely to notice improvement, partly because of genuine treatment effects and partly because of how your brain processes the experience.

Special Considerations for Breast Cancer Survivors

Hot flashes are frequently more severe in women being treated for breast cancer, especially those on tamoxifen or aromatase inhibitors. Estrogen therapy is generally off-limits for these women because of the risk of fueling hormone-sensitive tumors. Non-hormonal medications fill the gap, but with an important caveat: some SSRIs, specifically paroxetine and fluoxetine, can interfere with the enzyme that converts tamoxifen into its active form, potentially reducing the drug’s cancer-fighting effectiveness. Guidelines from the Quebec-based CEPO panel recommend that breast cancer patients on tamoxifen use venlafaxine, citalopram, clonidine, gabapentin, or pregabalin instead, and explicitly avoid paroxetine and fluoxetine.²⁷ Venlafaxine has been identified as the most effective single non-hormonal agent in this population.²⁸

Phytoestrogens like soy, black cohosh, and red clover deserve extra caution in breast cancer survivors. These substances are structurally similar to estradiol, and depending on the dose they can either block or mimic estrogen receptors. Their effect on estrogen-sensitive cancer cells is not well understood, and current evidence is not sufficient to assure women that these products are safe in that context.²⁹

Hot Flashes in Men on Androgen Deprivation Therapy

Hot flashes are not exclusively a female experience. Men undergoing androgen deprivation therapy (ADT) for prostate cancer lose testosterone abruptly, producing a hormonal shift analogous to menopause. The resulting hot flashes can be just as frequent and debilitating. Multiple non-hormonal medications and behavioral treatments developed for menopausal women have been adapted and studied in this population, with similar patterns of benefit.³⁰ Gabapentin, venlafaxine, and the cooling strategies described above are all options for men dealing with ADT-related flashes.

Stellate Ganglion Block as a Niche Procedure

A less conventional approach involves injecting a local anesthetic into the stellate ganglion, a cluster of nerves in the neck that feeds the sympathetic nervous system. A randomized trial of 40 perimenopausal women found that stellate ganglion block (SGB) significantly reduced hot flash scores over 12 weeks of follow-up, with transient hoarseness as the main side effect in about 10% of cases.³¹ A sham-controlled trial comparing SGB with saline injection found the procedure cut moderate-to-very-severe flashes by about half over four to six months, and an open-label trial in breast cancer survivors found SGB more effective than pregabalin.³² The evidence base is still small, and SGB requires a trained proceduralist and image guidance, so it is unlikely to become a first-line option. But for women who have exhausted other approaches, it is worth knowing about.

Hot Flashes May Signal Broader Health Risks

Treating hot flashes is not just about comfort. A growing body of evidence suggests that vasomotor symptoms may serve as a biomarker for longer-term health issues. The Study of Women’s Health Across the Nation found that women reporting hot flashes had significantly poorer blood-vessel function (measured by flow-mediated dilation) and greater calcification in both coronary arteries and the aorta, even after adjusting for standard cardiovascular risk factors and estrogen levels.³³ Reviews have expanded on this, describing an emerging link between vasomotor symptoms and cardiovascular disease, osteoporosis, and cognitive decline.³⁴

The bone-health angle has quantitative support as well. A systematic review and meta-analysis of observational studies found that women with vasomotor symptoms had roughly 54% higher odds of low bone mineral density, with the association particularly strong in the lumbar spine. The relationship held regardless of symptom severity, age, and study design.³⁵ None of this means hot flashes cause heart disease or osteoporosis directly. But it does mean that women with persistent, severe hot flashes may benefit from proactive cardiovascular and bone-health screening, regardless of which hot flash treatment they pursue.

How Prevalence Varies Around the World

Hot flashes are common almost everywhere, but not equally so. A systematic review of global prevalence data found that the frequency of hot flashes varies widely across societies and may be influenced by climate, diet, lifestyle, and cultural attitudes toward aging and the end of reproductive life.³⁶ A more recent meta-analysis found that high-income countries had a significantly lower prevalence of hot flashes (about 50%) compared to low-income countries (about 66%).³⁷ The reasons behind these disparities are still debated, with candidates including dietary differences (higher soy intake in East Asian populations, for instance), BMI patterns, physical activity levels, and even reporting bias influenced by whether a culture frames menopause as a medical event or a natural transition. What is clear is that while hot flashes are nearly universal, their intensity and how much they bother women vary enormously, which is one more reason a one-size-fits-all treatment approach does not make sense.